18.03.2018 17:06
|
Because of the potential for serious adverse reactions in nursing infants from CAFERGOT® (ergotamine tartrate and caffeine tablets, USP), a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother. Both drugs exhibit anticholinergic effects that may be additive. The risk or severity of adverse effects can be increased when Moexipril is combined with Nifedipine. If you have diabetes, this product may affect your blood sugar. The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Sarilumab. The amino acid sequences and the three-dimensional structures of the protease domains are homologous to the pancreatic serine proteases, chymotrypsin and trypsin. |